Literature DB >> 21908415

Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals.

Barry R Johns1, Alan C Pao, Sun H Kim.   

Abstract

BACKGROUND: Metabolic syndrome has been recently identified as a risk factor for chronic kidney disease (CKD). Since the five individual components of the metabolic syndrome have also been identified as risk factors for CKD, the metabolic syndrome diagnosis may represent an aggregate of CKD risk factors. On the other hand, the components of the metabolic syndrome are also associated with insulin resistance, which may directly mediate the increased CKD risk.
METHODS: This study was a cross-sectional evaluation of the relationship between metabolic syndrome, insulin resistance and estimated glomerular filtration rate (eGFR) in 574 non-diabetic individuals. Insulin resistance was directly quantified using the insulin suppression test, and the metabolic syndrome components were measured. eGFR was calculated using the three validated estimation equations: the Chronic Kidney Disease Epidemiology Collaboration equation, the Mayo quadratic equation and the Modification of Diet in Renal Disease study equation.
RESULTS: While CKD prevalence was higher and mean eGFR was lower in individuals who met the metabolic syndrome criteria compared with those who did not, we did not observe a significant relationship between insulin resistance and eGFR. Of all of the components of the metabolic syndrome, only hypertension was significantly associated with CKD prevalence [odds ratio (95% confidence interval), 3.5 (1.2-10.1), P=0.02].
CONCLUSION: Although CKD is more common among individuals with the metabolic syndrome, insulin resistance is not a common factor.

Entities:  

Mesh:

Year:  2011        PMID: 21908415      PMCID: PMC3315670          DOI: 10.1093/ndt/gfr498

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  37 in total

1.  Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease.

Authors:  Andrew D Rule; Timothy S Larson; Erik J Bergstralh; Jeff M Slezak; Steven J Jacobsen; Fernando G Cosio
Journal:  Ann Intern Med       Date:  2004-12-21       Impact factor: 25.391

2.  Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.

Authors:  J B Meigs; R B D'Agostino; P W Wilson; L A Cupples; D M Nathan; D E Singer
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

3.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.

Authors:  L G Hunsicker; S Adler; A Caggiula; B K England; T Greene; J W Kusek; N L Rogers; P E Teschan
Journal:  Kidney Int       Date:  1997-06       Impact factor: 10.612

4.  Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

Authors: 
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

5.  Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test.

Authors:  D Pei; C N Jones; R Bhargava; Y D Chen; G M Reaven
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

6.  Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.

Authors:  Manjula Kurella; Joan C Lo; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2005-05-18       Impact factor: 10.121

7.  Insulin resistance in patients with chronic kidney disease.

Authors:  Shuzo Kobayashi; Kyoko Maesato; Hidekazu Moriya; Takayasu Ohtake; Toshio Ikeda
Journal:  Am J Kidney Dis       Date:  2005-02       Impact factor: 8.860

8.  Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group.

Authors:  V M Buckalew; R L Berg; S R Wang; J G Porush; S Rauch; G Schulman
Journal:  Am J Kidney Dis       Date:  1996-12       Impact factor: 8.860

Review 9.  The metabolic syndrome: requiescat in pace.

Authors:  Gerald M Reaven
Journal:  Clin Chem       Date:  2005-03-03       Impact factor: 8.327

10.  Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp.

Authors:  M S Greenfield; L Doberne; F Kraemer; T Tobey; G Reaven
Journal:  Diabetes       Date:  1981-05       Impact factor: 9.461

View more
  12 in total

1.  Gender-specific association between metabolic syndrome and decreased glomerular filtration rate in elderly population.

Authors:  Jia Wen; Chen-Xian Guo; Ming-Gen Lu; Yao Lu; Yun Huang; Xing Liu; Ying Li; Zhi-Jun Huang; Ya-Ping Zhang; Hong Yuan
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

Review 2.  Metabolic syndrome in hypertensive patients: An unholy alliance.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Emilio Nardi; Giovanni Cerasola; Santina Cottone
Journal:  World J Cardiol       Date:  2014-09-26

3.  Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Michel Chonchol; Diana I Jalal
Journal:  Am J Nephrol       Date:  2012-11-02       Impact factor: 3.754

4.  DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.

Authors:  Annayya Aroor; Susan McKarns; Ravi Nistala; Vincent DeMarco; Michael Gardner; Mariana Garcia-Touza; Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2013-03-16       Impact factor: 2.041

5.  A blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: potential mechanism of TLR4-MAPK signaling pathway.

Authors:  Anand R Nair; Carrie M Elks; Jorge Vila; Fabio Del Piero; Daniel B Paulsen; Joseph Francis
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

6.  Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort.

Authors:  Negar Naderpoor; Jasmine G Lyons; Aya Mousa; Sanjeeva Ranasinha; Maximilian P J de Courten; Georgia Soldatos; Barbora de Courten
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

7.  Renal function markers and insulin sensitivity after 3 years in a healthy cohort, the EGIR-RISC study.

Authors:  Soline Siméon; Ziad Massy; Kurt Højlund; Katarina Lalic; Francesca Porcellati; Jacqueline Dekker; John Petrie; Gemma Currie; Beverley Balkau
Journal:  BMC Nephrol       Date:  2018-05-31       Impact factor: 2.388

8.  Kidney function and glucose metabolism in overweight and obese cats.

Authors:  L Pérez-López; M Boronat; C Melián; Y Brito-Casillas; A M Wägner
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

9.  Association between prediabetes (defined by HbA1C, fasting plasma glucose, and impaired glucose tolerance) and the development of chronic kidney disease: a 9-year prospective cohort study.

Authors:  Gwang Sil Kim; Hyun Ho Oh; Sang Hyun Kim; Byung Ok Kim; Young Sup Byun
Journal:  BMC Nephrol       Date:  2019-04-16       Impact factor: 2.388

Review 10.  Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link?

Authors:  L Orlić; I Mikolasevic; Z Bagic; S Racki; D Stimac; S Milic
Journal:  Gastroenterol Res Pract       Date:  2014-03-06       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.